<DOC>
	<DOCNO>NCT02908438</DOCNO>
	<brief_summary>The study design investigate effect luteal-phase administration gonadotrophin release hormone agonist ( GnRHa ) pregnancy outcomes in-vitro fertilization-embryo transfer .</brief_summary>
	<brief_title>Gonadotrophin Releasing Hormone Agonist Addition Luteal Support In-vitro Fertilization Embryo Transfer Cycles</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Age &lt; 37 year ; 2 . One high quality embryos get IVF/ICSI treatment ; 3 . To transfer l 2 fresh embryo ; 4 . Uterine endometrial thickness ≥ 7mm ; 5 . Patients sign informed consent . 1 . ≥3 IVF/ICSI/FET cycle pregnancy ; 2 . Polycystic ovary syndrome ( PCOS ) ; 3. uterine malformation ; 4. endometriosis 5. patient history recurrent pregnancy loss .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>